Literature DB >> 9512390

NCAM-180 knockout mice display increased lateral ventricle size and reduced prepulse inhibition of startle.

G K Wood1, H Tomasiewicz, U Rutishauser, T Magnuson, R Quirion, J Rochford, L K Srivastava.   

Abstract

NCAM-180 knockout mice, which have documented deficits in neural migration, were used to determine whether developmental abnormalities could lead to morphological changes and alterations in sensory motor gating mechanisms. Measurement of the lateral ventricle showed that NCAM-180-/- mice had marked increases in both the left and right anterior horns of the lateral ventricle. Furthermore, these mice also displayed a reduction of prepulse inhibition that was differentially affected by the dopamine agonist apomorphine. These results are discussed in light of the known increase in lateral ventricle size and reduction in prepulse inhibition that are seen in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9512390     DOI: 10.1097/00001756-199802160-00019

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  20 in total

Review 1.  Animal models of schizophrenia: a critical review.

Authors:  E R Marcotte; D M Pearson; L K Srivastava
Journal:  J Psychiatry Neurosci       Date:  2001-11       Impact factor: 6.186

2.  Neural cell adhesion molecule-associated polysialic acid regulates synaptic plasticity and learning by restraining the signaling through GluN2B-containing NMDA receptors.

Authors:  Gaga Kochlamazashvili; Oleg Senkov; Sergei Grebenyuk; Catrina Robinson; Mei-Fang Xiao; Katharina Stummeyer; Rita Gerardy-Schahn; Andreas K Engel; Larry Feig; Alexey Semyanov; Vishnu Suppiramaniam; Melitta Schachner; Alexander Dityatev
Journal:  J Neurosci       Date:  2010-03-17       Impact factor: 6.167

3.  Loss of function studies in mice and genetic association link receptor protein tyrosine phosphatase α to schizophrenia.

Authors:  Nagahide Takahashi; Karin Sandager Nielsen; Branko Aleksic; Steffen Petersen; Masashi Ikeda; Itaru Kushima; Nathalie Vacaresse; Hiroshi Ujike; Nakao Iwata; Véronique Dubreuil; Naheed Mirza; Takeshi Sakurai; Norio Ozaki; Joseph D Buxbaum; Jan Sap
Journal:  Biol Psychiatry       Date:  2011-08-10       Impact factor: 13.382

4.  Restoration of synaptic plasticity and learning in young and aged NCAM-deficient mice by enhancing neurotransmission mediated by GluN2A-containing NMDA receptors.

Authors:  Gaga Kochlamazashvili; Olena Bukalo; Oleg Senkov; Benedikt Salmen; Rita Gerardy-Schahn; Andreas K Engel; Melitta Schachner; Alexander Dityatev
Journal:  J Neurosci       Date:  2012-02-15       Impact factor: 6.167

5.  Consequences of neural cell adhesion molecule deficiency on cell migration in the rostral migratory stream of the mouse.

Authors:  G Chazal; P Durbec; A Jankovski; G Rougon; H Cremer
Journal:  J Neurosci       Date:  2000-02-15       Impact factor: 6.167

Review 6.  Schizophrenia: an integrative approach to modelling a complex disorder.

Authors:  George S Robertson; Sarah E Hori; Kelly J Powell
Journal:  J Psychiatry Neurosci       Date:  2006-05       Impact factor: 6.186

7.  Correlation between cataleptic freezing and prepulse inhibition of the startle reflex in rats.

Authors:  N N Barykina; T A Alekhina; V F Chugui; O I Petrenko; N K Popova; V G Kolpakov
Journal:  Neurosci Behav Physiol       Date:  2004-05

Review 8.  Pre-attentive processing and schizophrenia: animal studies.

Authors:  Bart A Ellenbroek
Journal:  Psychopharmacology (Berl)       Date:  2003-12-04       Impact factor: 4.530

9.  Developmental regulation of neural cell adhesion molecule in human prefrontal cortex.

Authors:  E T Cox; L H Brennaman; K L Gable; R M Hamer; L A Glantz; A-S Lamantia; J A Lieberman; J H Gilmore; P F Maness; L F Jarskog
Journal:  Neuroscience       Date:  2009-04-22       Impact factor: 3.590

Review 10.  The evolution of drug development in schizophrenia: past issues and future opportunities.

Authors:  William T Carpenter; James I Koenig
Journal:  Neuropsychopharmacology       Date:  2007-11-28       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.